The Middle East DNA synthesis market size accounted for USD 200.00 billion in 2025 and is predicted to touch around USD 994.74 billion by 2035, growing at a CAGR of 17.4% from 2026 to 2035.Growing due to improving healthcare systems and genomics research focus.

Middle East DNA Synthesis Market Statical Scope

The expansion of the market is supported by rising investments in healthcare infrastructure. DNA synthesis technologies are becoming more popular as interest in genomics research grows. The capacity for life sciences research is being improved by public-private partnerships. Demand for genetic solutions is rising as disease prevention becomes more important.

Middle East DNA Synthesis Market, By Service Type, 2025 (%)

• Oligonucleotide Synthesis- Oligonucleotide synthesis dominates the market with a share of 72%, driven by rising demand for PCR sequencing and synthetic biology applications.
• Gene Library Synthesis- Gene library synthesis holds a notable share of 28% driven by increasing use in large-scale gene discovery and functional genomics studies.

Middle East DNA Synthesis Market, By Application, 2025 (%)

• Research & Development- Research & development dominates the market with a share of 62% driven by growing investments in genomics, drug discovery , and biotechnology innovation.
• Diagnostics- Diagnostics holds a smaller share of 18% and is driven by expanding the adoption of molecular diagnostics and early disease detection tools.
• Therapeutics- Therapeutics is gaining momentum with a share of 20% driven by the rising development of gene therapies and nucleic acid-based treatments.

Middle East DNA Synthesis Market, By End Use, 2025 (%)

• Biopharma & Diagnostics Companies- Biopharma & diagnostics companies dominate the market with a share of 48%, driven by strong pipelines in biologics and precision medicine .
• Academic & Research Institutes- Academic & research institutes account for 32% of the market driven by increased government funding and advanced life science research programs.
• CROs- CROs are gaining momentum with a share of 20% driven by growing outsourcing of research and synthesis services for cost and efficiency advantages.

Top Companies in the Middle East DNA Synthesis Market

• Thermo Fisher Scientific, Inc
• Twist Bioscience
• BIONEER CORPORATION
• Eton Bioscience, Inc.
• LGC Biosearch Technologies
• IBA Lifesciences GmbH
• Eurofins Scientific
• Integrated DNA Technologies, Inc.
• Quintara Biosciences
• GenScript

Segments Covered in the Report

By Service Type

• Oligonucleotide Synthesis
  • By Type
    • Standard Oligonucleotide Synthesis
    • Custom Oligonucleotide Synthesis
  • By Length
    • Less than 50 nt
    • 51-100 nt
    • 101-150 nt
    • More than 150 nt
• Gene Synthesis
  • By Type
    • Custom Gene Synthesis
    • Gene Library Synthesis
  • By Length
    • Less than 500 nt
    • 501-1000 nt
    • 1001-1500 nt
    • 1501-2000 nt
    • 2001-2500 nt
    • More than 2500 nt

By Application

• Research and Development
  • Oligonucleotide Synthesis
    • PCR
    • NGS
    • CRISPR
    • Cloning and Mutagenesis
    • Others
  • Gene Synthesis
    • Synthetic Biology
    • Vaccine Development
    • Genetic Engineering
    • Others
• Diagnostics
• Therapeutics
  • RNAi Therapies
  • Antisense Oligonucleotide-based Therapies
  • Others

By End use

• Biopharmaceutical & Diagnostics Companies
• Academic & Research Institutes
• Contract Research Organizations